Quarterly report pursuant to Section 13 or 15(d)

Note 7 - Investment in Macrophage Therapeutics, Inc. (Details Textual)

v3.21.1
Note 7 - Investment in Macrophage Therapeutics, Inc. (Details Textual) - New York Litigation Involving Former CEO and President [Member] - Judicial Ruling [Member]
Apr. 21, 2021
USD ($)
Litigation Settlement, Amount Can Be Awarded to Other Party for Indemnification for Attorneys’ Fees $ 14,955
Litigation Settlement, Amount Can Be Advanced to Other Party for Attorneys’ Fees Subject to Repayment $ 1,237.50